Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01490177 · ClinicalTrials.gov registry record · Phase 1
Single Center Food Allergy Oral Immunotherapy Study
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT01490177: Completed Phase 1 study, sponsored by Stanford University.
NCT01490177 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01490177, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
The Primary Objective of the study is to develop a customized regimen for oral immunotherapy that reflects what the subject is allergic in a clinically significant way (i.e., the offending food allergen is defined as a food allergen with a positive skin test or positive specific IgE and a positive DBPCFC). Therefore, the investigators prefer that both single and multiple food allergy subjects are included in the study.
Interventions
- DRUG Food proteins
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-11 |
| Est. Completion | 2014-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01490177
The ClinicalTrials.gov registry entry for NCT01490177 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Food proteins is the first listed.
NCT01490177 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01490177 about?
NCT01490177 is a clinical study titled "Single Center Food Allergy Oral Immunotherapy Study". The Primary Objective of the study is to develop a customized regimen for oral immunotherapy that reflects what the subject is allergic in a clinically significant way (i.e., the offending food allergen is defined as a food allergen with a positive skin test or positive specific IgE and a positive D...
What is the current status of trial NCT01490177?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2011-11. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01490177?
The interventions under investigation include: Food proteins (DRUG).
Who is sponsoring clinical trial NCT01490177?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.